Pancreatic Cancer Research

ResearcherChinese PLA General HospitalNo recent work listed

Minggen Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7933-7850; OpenAlex author ID A5043321678. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 3 papers

Papers 11

  1. Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center. Co-author DOI 10.1016/j.hbpd.2022.09.006↗
  2. Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.hbpd.2022.09.009↗
  3. Early and late recurrence patterns of pancreatic ductal adenocarcinoma after pancreaticoduodenectomy: a multicenter study. Co-author DOI 10.1097/js9.0000000000000296↗
  4. A novel online calculator to predict early recurrence and long-term survival of patients with resectable pancreatic ductal adenocarcinoma after pancreaticoduod… Co-author DOI 10.1016/j.ijsu.2022.106891↗
  5. Up-regulation of S100P predicts the poor long-term survival and construction of prognostic signature for survival and immunotherapy in patients with pancreatic… Co-author DOI 10.1080/21655979.2021.1992331↗
  6. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. Co-author DOI 10.2217/fon-2021-0495↗
  7. Leukemia-related protein 16 (LRP16) promotes tumor growth and metastasis in pancreatic cancer. First author DOI 10.2147/ott.s157914↗
  8. GDF11 restrains tumor growth by promoting apoptosis in pancreatic cancer. Last author DOI 10.2147/ott.s181792↗
  9. MicroRNA-4656 is a prognostic factor and tumor suppressor in human pancreatic cancer through a downstream target of TrkA. Last author DOI 10.1002/jgm.2938↗
  10. Clinical Significance of Preoperative CD8+ Central Memory T Cells for Operable Pancreatic Adenocarcinoma. Co-author DOI 10.1159/000440681↗
  11. [Preoperative neutrophil-lymphocyte ratio as an independent prognostic predictor for pancreatic cancer]. Co-author PMID 26710955↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rong Liu · 8 shared papers, 2015–2023 · strength 1.15
  2. Zhiming Zhao · 6 shared papers, 2015–2023 · strength 0.86
  3. Xiuping Zhang · 4 shared papers, 2022–2023 · strength 0.74
  4. Shuai Xu · 3 shared papers, 2022–2023 · strength 0.55
  5. Wenbo Zou · 3 shared papers, 2021–2023 · strength 0.49
  6. Qu Liu · 2 shared papers, 2023 · strength 0.39
  7. Zizheng Wang · 3 shared papers, 2018–2021 · strength 0.39
  8. Shuai Xu · 1 shared paper, 2023 · strength 0.18
  9. Wan Yee Lau · 1 shared paper, 2023 · strength 0.18
  10. Lincheng Li · 1 shared paper, 2021 · strength 0.15
  11. Fei Wang · 1 shared paper, 2021 · strength 0.15
  12. Gong Zhang · 1 shared paper, 2021 · strength 0.15
  13. Yongjie Wu · 2 shared papers, 2015 · strength 0.12
  14. Mo Zheng · 1 shared paper, 2018 · strength 0.10
  15. Shunchang Jiao · 1 shared paper, 2018 · strength 0.10
  16. Wei Jing · 1 shared paper, 2018 · strength 0.09
  17. Yanzhe Liu · 1 shared paper, 2018 · strength 0.09
  18. Chenggang Li · 1 shared paper, 2017 · strength 0.08
  19. Tan X · 1 shared paper, 2017 · strength 0.08
  20. Zhiming Zhao · 1 shared paper, 2017 · strength 0.08
  21. Hailiang Liu · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.